Guillermo Streich

Centro Médico Austral

关注

立即认领

关注

立即认领

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 6 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

EMERALD Phase 3 Trial of Elacestrant Versus Standard of Care Endocrine Therapy in Patients with ER+/HER2-metastatic Breast Cancer: Updated Results by Duration of Prior CDK4/6i in Metastatic Setting

Aditya Bardia,Francois-Clement Bidard,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frederic Forget,Marie-Ange Mouret-Reynier,Joo Hyuk Sohn,Donatienne Taylor,Kathleen K. Harnden,Hung Khong,Judit Kocsis,Florence Dalenc,Patrick Dillon,Sunil Babu,Simon Waters,Ines Deleu,Jose Angel Garcia-Saenz,Emilio Bria,Marina Elena Cazzaniga,Philippe Aftimos,Javier Cortes,Giulia Tonini,Tarek Sahmoud,Nassir Habboubi,Krzysztof Grzegorzewski,Virginia Kaklamani

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Abstract GS3-01: GS3-01 EMERALD Phase 3 Trial of Elacestrant Versus Standard of Care Endocrine Therapy in Patients with ER+/HER2- Metastatic Breast Cancer: Updated Results by Duration of Prior CDK4/6i in Metastatic Setting

Aditya Bardia,Francois-Clement Bidard,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frederic Forget,Marie-Ange Mouret-Reynier,Joo Hyuk Sohn,Donatienne Taylor,Kathleen K. Harnden,Hung Khong,Judit Kocsis,Florence Dalenc,Patrick Dillon,Sunil Babu,Simon Waters,Ines Deleu,Jose Angel García-Sáenz,Emilio Bria,Marina Elena Cazzaniga,Philippe Aftimos,Javier Cortés,Giulia Tonini,Tarek Sahmoud,Nassir Habboubi,Krzysztof Grzegorzewski,Virginia Kaklamani

Cancer Researchno. 5_Supplement (2023): GS3-01

引用18浏览0引用

Elacestrant, an oral selective estrogen receptor degrader (SERD), vs investigator's choice of endocrine monotherapy for ER+/HER2-advanced/metastatic breast cancer (mBC) following progression on prior endocrine and CDK4/6 inhibitor therapy: Results of EMERALD phase 3 trial

Aditya Bardia,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frederic Forget,Marie-Ange Mouret-Reynier,Joo Hyuk Sohn,Peter Vuylsteke,Kathleen K. Harnden,Hung Khong,Judit Kocsis,Florence Dalenc,Virginia Kaklamani,Patrick Dillon,Sunil Babu,Simon Waters,Ines Deleu,Jose Garcia-Saenz,Emilio Bria,Marina Cazzaniga,Janice Lu,Philippe Aftimos,Javier Cortes,Shubin Liu,Dirk Laurent,Maureen G. Conlan,Francois-Clement Bidard

CANCER RESEARCH（2022）

引用0浏览0引用

Elacestrant (oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results from the Randomized Phase III EMERALD Trial

Francois-Clement Bidard,Virginia G. Kaklamani,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frederic Forget,Marie-Ange Mouret-Reynier,Joo Hyuk Sohn,Donatienne Taylor,Kathleen K. Harnden,Hung Khong,Judit Kocsis,Florence Dalenc,Patrick M. Dillon,Sunil Babu,Simon Waters,Ines Deleu,Jose A. Garcia Saenz,Emilio Bria,Marina Cazzaniga,Janice Lu,Philippe Aftimos,Javier Cortes,Shubin Liu,Giulia Tonini,Dirk Laurent,Nassir Habboubi,Maureen G. Conlan,Aditya Bardia

Journal of Clinical Oncology（2022）

引用303浏览0WOS引用

303

Abstract GS2-02: Elacestrant, an Oral Selective Estrogen Receptor Degrader (SERD), Vs Investigator’s Choice of Endocrine Monotherapy for ER+/HER2- Advanced/metastatic Breast Cancer (mbc) Following Progression on Prior Endocrine and CDK4/6 Inhibitor Therapy: Results of EMERALD Phase 3 Trial

Aditya Bardia,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frédéric Forget,Marie-Ange Mouret-Reynier,Joo Hyuk Sohn,Peter Vuylsteke,Kathleen K. Harnden,Hung Khong,Judit Kocsis,Florence Dalenc,Virginia Kaklamani,Patrick Dillon,Sunil Babu,Simon Waters,Ines Deleu,José García-Sáenz,Emilio Bria,Marina Cazzaniga,Janice Lu,Philippe Aftimos,Javier Cortes,Shubin Liu,Dirk Laurent,Maureen G. Conlan,Francois-Clement Bidard

Cancer Research（2022）

引用17浏览0引用

Subgroup Analysis of Patients with No Prior Chemotherapy in EMERALD: A Phase 3 Trial Evaluating Elacestrant, an Oral Selective Estrogen Receptor Degrader (SERD), Versus Investigator's Choice of Endocrine Monotherapy for ER+/HER2-advanced/metastatic Breast Cancer (Mbc)

Virginia G. Kaklamani,Aditya Bardia,Philippe Georges Aftimos,Javier Cortes,Janice M. Lu,Patrick Neven,Guillermo Streich,Alberto J. Montero,Frederic Forget,Marie-Ange Mouret-Reynier,Joohyuk Sohn,Donatienne Taylor,Kathleen Kiernan Harnden,Hung T. Khong,Judit Kocsis,Florence Dalenc,Patrick Michael Dillon,Giulia Tonini,Kris Grzegorzewski,Francois-Clement Bidard

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用6浏览0引用

作者统计

#Papers: 6

#Citation: 344

H-Index: 4

G-Index: 4

Sociability: 4

Diversity: 1

Activity: 16

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn